LLNI Funded Publications

Microarray classification of myelodysplastic syndrome (MDS) identifies subgroups with distinct clinical outcomes and identifies patients with high risk of AML transformation

Author:KI Mills

Other Authors: A Kohlmann, PM Williams, L Wieczorek, W-M Liu, R Li, W Wen, DT Bowen, H Loeffler, JM Hernandez, W-K Hofmann, T Haferlach,


Date: May  2009

Friends of L&LNI
The Institute of Hospitality NI
Get in touch

028 9097 2928

Leukaemia & Lymphoma NI,
Patrick G Johnston Centre for Cancer Research, 97 Lisburn Rd, Belfast BT9 7AE

© Copyright Leukaemia & Lymphoma NI 2024 | Charity Registration No: 105452 | Privacy Policy